Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
Open Access
- 4 December 2019
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 21 (1) , 1-10
Abstract
Background: Available data proving the value of DWI for breast cancer diagnosis is mainly for enhancing masses; DWI may be less sensitive and specific in non-mass enhancement (NME) lesions. The objective of this study was to assess the diagnostic accuracy of DWI using different ROI measurement approaches and ADC metrics in breast lesions presenting as NME lesions on dynamic contrast-enhanced (DCE) MRI. Methods: In this retrospective study, 95 patients who underwent multiparametric MRI with DCE and DWI from September 2007 to July 2013 and who were diagnosed with a suspicious NME (BI-RADS 4/5) were included. Twenty-nine patients were excluded for lesion non-visibility on DWI (n = 24: 12 benign and 12 malignant) and poor DWI quality (n = 5: 1 benign and 4 malignant). Two readers independently assessed DWI and DCE-MRI findings in two separate randomized readings using different ADC metrics and ROI approaches. NME lesions were classified as either benign (> 1.3 × 10−3 mm2/s) or malignant (≤ 1.3 × 10−3 mm2/s). Histopathology was the standard of reference. ROC curves were plotted, and AUCs were determined. Concordance correlation coefficient (CCC) was measured. Results: There were 39 malignant (59%) and 27 benign (41%) lesions in 66 (65 women, 1 man) patients (mean age, 51.8 years). The mean ADC value of the darkest part of the tumor (Dptu) achieved the highest diagnostic accuracy, with AUCs of up to 0.71. Inter-reader agreement was highest with Dptu ADC max (CCC 0.42) and lowest with the point tumor (Ptu) ADC min (CCC = − 0.01). Intra-reader agreement was highest with Wtu ADC mean (CCC = 0.44 for reader 1, 0.41 for reader 2), but this was not associated with the highest diagnostic accuracy. Conclusions: Diagnostic accuracy of DWI with ADC mapping is limited in NME lesions. Thirty-one percent of lesions presenting as NME on DCE-MRI could not be evaluated with DWI, and therefore, DCE-MRI remains indispensable. Best results were achieved using Dptu 2D ROI measurement and ADC mean.Keywords
This publication has 35 references indexed in Scilit:
- Diffusion‐Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b‐ValuesJournal of Magnetic Resonance Imaging, 2019
- Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialJournal of Magnetic Resonance Imaging, 2018
- Abbreviated MRI of the Breast: Does It Provide Value?Journal of Magnetic Resonance Imaging, 2018
- Diffusion‐weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracyNMR in Biomedicine, 2016
- Multiparametrische und molekulare Bildgebung von Brusttumoren mit MRT und PET‑MRTDer Radiologe, 2016
- Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesionsJournal of Magnetic Resonance Imaging, 2013
- Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variabilityEuropean Radiology, 2011
- Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesionsEuropean Radiology, 2009
- Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesionEuropean Radiology, 2007
- Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imagingJournal of Magnetic Resonance Imaging, 2002